Mateo excellent deduction of patient numbers. Beats me counting names on facebook pages.
What I do recall (and hopefully correctly) is that Acadia have approximately 50 'sales' staff on their books working every day to help families get their child signed up and approved.
Even if it's 1 patient per week per staff member that's 2500 for the year. I can imagine their KPI's would be more than 1 per week.
Should not take more than 2 years to get all those on the register on board, that being over 4000.
In the meantime diagnosis and registration should grow to the 6000-9000 as the suggested prevalence indicates.
So forecasting 4000-5000 in 3-4 years is not unreasonable, or US$1.5b revenue or about AUD$275m profit to Neuren just from Daybue Retts North America.
ROW had forecast about another US$600m of revenue so add a further ~ AUD$120m (@18-20%) to Neuren.
Lets round it off to AUD$400m revenue to Neuren by then.
I kid you not. Please show me figures that refute those.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren and Acadia expand global partnership for trofinetide
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.54

Ann: Neuren and Acadia expand global partnership for trofinetide, page-107
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.000(0.00%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.32 | $7.219M | 577.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2968 | $12.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.57 | 540 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2 | 12.830 |
1 | 7680 | 12.630 |
2 | 224 | 12.550 |
1 | 200 | 12.530 |
1 | 79 | 12.520 |
Price($) | Vol. | No. |
---|---|---|
12.500 | 998 | 1 |
12.630 | 187 | 1 |
12.700 | 300 | 1 |
12.750 | 300 | 1 |
12.800 | 78 | 1 |
Last trade - 16.16pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online